We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an unpredictable path for the industry this year.

AI-based R&D companies like Turing Labs are reinventing the product development lifecycle, swapping spreadsheets for intuitive web-based interfaces and virtual assistants.

When it comes to AI, 2025 and 2026 are going to be the years of “real differentiation in the market between the companies who ...

Business and nonprofit leaders participated in a wide-ranging TIME100 Talk at the World Economic Forum’s meeting in Davos, ...